James provides analytic leadership in the areas of research design and implementation, clinical program evaluation, and business capability development. James specializes in the use of advanced analytics to achieve research objectives for provider networks, pharmaceutical companies, and health plans.
Prior to joining Inovalon, James was a senior data scientist with Cigna Healthcare. He consulted with the business and brought matrix partners together to deliver valuable insights and recommendations for the commercially insured population. These engagements drove the expansion of clinical programs in areas such as pre-disability, chronic conditions, lifestyle management, and high-risk maternity.
James has an extensive background in healthcare, including the Centers for Medicare and Medicaid Services’ National Committee for Quality Assurance’s Healthcare Effectiveness Data and Information Set compliance reporting for value-based care and quality improvement. He spent 5 years as an analytic lead for Community Care of North Carolina supporting Medicaid and Medicare managed care. He also focused on quality improvement reporting and outcomes measurement for the North Carolina Medicaid Children’s Health Insurance Program population.
James holds an MS in advanced analytics from North Carolina State University, an MS in network communications, and a BS in information systems from the University of Colorado. He is currently working on a PhD in research methods at the University of North Carolina.
Economic Burden of Metastatic Castration Resistant Prostate Cancer, By LINE of Treatment, in Medicare Beneficiaries, 2014-2019
This retrospective study describes healthcare resource utilization (HRU) and cost of care, by line of therapy (LOT), in Medicare Fee-for-Service...
Economic Burden of Metastatic Castration Resistant Prostate Cancer, By LINE of Treatment, in Medicare Beneficiaries, 2014-2019
Accepted for presentation at ISPOR 2022. Findings available upon request. Contact us for more information.
Impact of Race/Ethnicity and Socioeconomic Status on Emergency Department Visits in Patients with Hepatocellular Carcinoma
Despite advances in diagnosis and treatment of hepatocellular carcinoma (HCC), disparities in care utilization and health outcomes persist. Few studies...
Impact of Race/Ethnicity and Socioeconomic Status on Emergency Department Visits in Patients with Hepatocellular Carcinoma
Accepted for presentation at 2022 ASCO GI Symposium. Findings available upon request. Contact us for more information.
Real-world survival of U.S. patients with intermediate- to high-risk myelofibrosis: Impact of ruxolitinib approval
The Janus kinase inhibitor ruxolitinib is approved for the treatment of myelofibrosis (MF) and improved overall survival (OS) versus control...
Characteristics, Cost And Health Care Resource Use in a Population of Medicare Fee-For-Service (FFS) Patients with Chronic Obstructive Pulmonary Disease (COPD) Who Also Experience Pneumonia
Accepted for presentation at ISPOR 2021. Findings available upon request. Contact us for more information.